Top Markets
#1 Derive Derive +31.23%
#2 Cross Cross +14.51%
#3 Geodnet Geodnet +13.18%
#4 Gama Token Gama Token +9.16%
#5 Steakhouse ETH Morpho Vault Steakhouse ETH Morpho Vault +7.47%
#6 Talus Network Talus Network +7.24%
#7 Codatta Codatta +6.12%
#8 Humanity Humanity +5.46%
#9 Based Based +5.42%
#10 龙虾 (Lobster) 龙虾 (Lobster) +5.22%
Coin of the day
Derive Derive
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Telo Genomics Corp. Telo Genomics Corp.

Telo Genomics Corp.

TELO
Classement en actions #35884
Telo Genomics Corp. (TELO.V) operates as a biotechnology firm focused on... Telo Genomics Corp. (TELO.V) operates as a biotechnology firm focused on creating and bringing to market advanced predictive solutions. Its core mission is to enable personalized treatment approaches for individuals suffering from specific health conditions. The company's primary innovation is a sophisticated telomere analysis platform, which serves both to diagnose diseases and to forecast patient outcomes. This technology, often integrated with liquid biopsies, provides crucial insights for applications in both cancer and neurological illnesses. Their leading product, Telo-MM, is specifically designed to arm medical professionals with vital, actionable information for effectively managing Multiple Myeloma, a serious blood cancer. Additionally, Telo Genomics offers TeloView, a proprietary software system capable of precisely measuring individual patient telomere characteristics. Telo Genomics caters to a broad spectrum of clients, including diagnostic pathologists, clinical doctors, academic researchers, and pharmaceutical developers. A notable endorsement of its technology is a collaborative agreement with the renowned Mayo Clinic, aimed at validating the Telo-MM diagnostic tests for multiple myeloma. Founded in 2014 and based in Toronto, Canada, the company adopted its current name, Telo Genomics Corp., in April 2019, having previously operated as 3D Signatures Inc.
Prix de l'action
$0.03302716
Dernière synchronisation: 2026-08-13
Capitalisation boursière
$3.32M
Changement (1 jour)
0.00%
Changement (1 an)
-34.80%
Pays
CA
Échange Telo Genomics Corp. (TELO)

Catégorie

Healthcare
Le prix TELO avec la capitalisation boursière de B
Telo Genomics Corp. Telo Genomics Corp.
TELO
$0.03302716
Capitalisation boursière de Telo Genomics Corp.(TELO)
Capitalisation boursière: $3.32M
En August 2026, Telo Genomics Corp. a une capitalisation boursière de $3.32M. Cela fait de Telo Genomics Corp. la 35884th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Telo Genomics Corp. du 2012 au 2026
TELO par rapport au top 5 des plus populaires stocks
Prix pour TELO L’actif B La capitalisation boursière de B Résultats
Telo Genomics Corp. Telo Genomics Corp.
$54,282.96 $3.32M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.452T +164,358,437.43%
Telo Genomics Corp. Telo Genomics Corp.
$44,706.07 $3.32M
Apple Inc. Apple Inc.
AAPL
$4.490T +135,361,428.22%
Telo Genomics Corp. Telo Genomics Corp.
$41,444.10 $3.32M
Alphabet Inc. Alphabet Inc.
GOOG
$4.162T +125,484,809.62%
Telo Genomics Corp. Telo Genomics Corp.
$36,604.47 $3.32M
Microsoft Corporation Microsoft Corporation
MSFT
$3.676T +110,831,324.38%
Telo Genomics Corp. Telo Genomics Corp.
$28,207.94 $3.32M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.833T +85,408,197.71%